Dana Farber Cancer Institute (Data Collection and Specimen Analysis) is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Dana Farber Cancer Institute (Data Collection and Specimen Analysis) has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Central Nervous System Lymphoma, Mantle Cell Lymphoma, MCL.
Sponsors: Memorial Sloan Kettering Cancer Center.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Farber Cancer Institute (Data Collection and Specimen Analysis) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber Cancer Institute (Data Collection and Specimen Analysis) has 2 clinical trials on record, with 2 currently active. Their work covers Central Nervous System Lymphoma, Mantle Cell Lymphoma, MCL.
Dana Farber Cancer Institute (Data Collection and Specimen Analysis) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.